ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Repligen Corp

Repligen Corp (RGEN)

152,81
2,19
(1,45%)
À la fermeture: 17 Mars 9:00PM
152,81
0,01
( 0,01% )
Après les heures de négociation: 10:54PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
152,81
Prix Achat
149,28
Prix Vente
156,31
Volume échangé
481 685
147,99 Fourchette du Jour 153,89
113,50 Plage de 52 semaines 200,23
Cap du marché
Clôture Veille
150,62
Ouverture
150,42
Dernière Transaction
1
@
153.98
Dernière heure de transaction
22:54:21
Volume financier
US$ 73 447 493
VWAP
152,4803
Volume moyen (3 m)
609 123
Actions en circulation
56 026 725
Rendement du Dividende
-
Ratio Cours sur Bénéfices
240,52
Bénéfice par action (BPA)
0,64
Chiffre d'affairess
662,93M
Bénéfice net
35,6M

À propos de Repligen Corp

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Repligen Corp est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker RGEN. Le dernier cours de clôture d'Repligen était de US$150,62. Au cours de la dernière année, les actions de Repligen ont été négociées dans une fourchette de prix de US$ 113,50 à US$ 200,23.

Repligen compte actuellement 56 026 725 actions en circulation. La capitalisation boursière d'Repligen est de US$8,44 milliard. Repligen a un ratio cours/bénéfice (ratio PE) de 240.52.

Flux d'options Repligen (RGEN)

Flux global

Baissier

Prime nette

-722k

Calls / Puts

0,00%

Ach. / Vent.

0,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

RGEN Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.641.08487133691151.17152.81135.685865112143.11687963CS
45.523.74770860208147.29169135.685796847153.78506123CS
128.766.08122179799144.05181.66135.685609123156.19777585CS
2612.068.56838365897140.75181.66121.52611430148.43547076CS
52-39.13-20.3865791393191.94200.23113.5661999148.84452662CS
156-23.07-13.1168978849175.88262.26110.45604077164.69014967CS
26064.1772.393953068688.64327.3278.41537627171.19824067CS

RGEN - Frequently Asked Questions (FAQ)

What is the current Repligen share price?
The current share price of Repligen is US$ 152,81
How many Repligen shares are in issue?
Repligen has 56 026 725 shares in issue
What is the market cap of Repligen?
The market capitalisation of Repligen is USD 8,44B
What is the 1 year trading range for Repligen share price?
Repligen has traded in the range of US$ 113,50 to US$ 200,23 during the past year
What is the PE ratio of Repligen?
The price to earnings ratio of Repligen is 240,52
What is the cash to sales ratio of Repligen?
The cash to sales ratio of Repligen is 12,91
What is the reporting currency for Repligen?
Repligen reports financial results in USD
What is the latest annual turnover for Repligen?
The latest annual turnover of Repligen is USD 662,93M
What is the latest annual profit for Repligen?
The latest annual profit of Repligen is USD 35,6M
What is the registered address of Repligen?
The registered address for Repligen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Repligen website address?
The website address for Repligen is www.repligen.com
Which industry sector does Repligen operate in?
Repligen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RGCRegencell Bioscience Holdings Ltd
US$ 32,1123
(73,58%)
560,85k
GNPXGenprex Inc
US$ 0,5273
(31,83%)
1,84M
HROWHarrow Inc
US$ 27,75
(19,00%)
223,18k
DXSTDecent Holding Inc
US$ 1,19
(15,53%)
267
COEPCoeptis Therapeutics Holdings Inc
US$ 9,75
(14,71%)
24,93k
ATXIAvenue Therapeutics Inc
US$ 0,499502
(-41,38%)
84,6k
AGMHAGM Group Holdings Inc
US$ 0,08
(-24,24%)
11,12M
VRPXVirpax Pharmaceuticals Inc
US$ 0,1299
(-23,14%)
1,18M
ANTEAirNet Technology Inc
US$ 1,25
(-22,36%)
2,44M
KYTXKyverna Therapeutics Inc
US$ 2,0185
(-20,53%)
20,57k
AGMHAGM Group Holdings Inc
US$ 0,08
(-24,24%)
11,12M
HEPAHepion Pharmaceuticals Inc
US$ 0,02015
(-3,13%)
4,66M
SCNXScienture Holdings Inc
US$ 2,06
(-16,94%)
4,48M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0778
(-7,71%)
4,39M
LCIDLucid Group Inc
US$ 2,19
(1,39%)
3,4M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock